Ciclosporin Use During Pregnancy Karolina PazianaMagaly Del MonacoVincent Armenti Review Article 21 March 2013 Pages: 279 - 294
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval) Rashmi R. ShahJoel MorganrothDevron R. Shah Review Article 26 April 2013 Pages: 295 - 316
Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review Cristian Gonzalez-GonzalezElena Lopez-GonzalezAdolfo Figueiras Systematic Review 03 May 2013 Pages: 317 - 328
Ischaemic Colitis in Rheumatoid Arthritis Patients Receiving Tumour Necrosis Factor-α Inhibitors: An Analysis of Reports to the US FDA Adverse Event Reporting System Allison SalkDerrick J. StobaughEli D. Ehrenpreis Short Communication 12 April 2013 Pages: 329 - 334
Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project June M. McKoyMatthew J. FisherDennis P. West Original Research Article 04 April 2013 Pages: 335 - 347
Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso Lassane KaborePascal MilletFrançoise Haramburu Original Research Article 12 April 2013 Pages: 349 - 358
Effects of Maternal Epilepsy and Antiepileptic Drug Use during Pregnancy on Perinatal Health in Offspring: Nationwide, Retrospective Cohort Study in Finland Miia ArtamaMika GisslerThe Drug and Pregnancy Group Original Research Article 25 April 2013 Pages: 359 - 369
The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions Johanna StrandellOla CasterG. Niklas Norén Original Research Article 03 May 2013 Pages: 371 - 388